定义帕金森病:过去和未来
Kristina Kulcsarova1,2,3, Matej Skorvanek1,2, Ronald B Postuma4
1Department of Neurology, P. J. Safarik University, Kosice, Slovak Republic.
Journal of Parkinson's disease
|March 15, 2024
概括
帕金森病 (PD) 诊断正在从临床症状转向生物标志物. 通过α-synuclein,神经退行和遗传学的早期检测旨在为未来的疾病修饰疗法.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病.
- 目前的诊断标准依赖于晚期运动症状,延迟干预.
- 了解PD病理生理学对于早期检测至关重要.
研究的目的:
- 审查帕金森病定义的演变.
- 倡导转向对PD的生物学定义.
- 探索早期诊断标记,以寻找潜在的疾病修饰疗法.
主要方法:
- 关于PD诊断标准和进展的文献综述.
- 对PD新出现的生物标志物的分析.
- 在生物 PD 定义中讨论这些标记物的应用.
主要成果:
- 历史上的PD定义是基于临床运动征兆.
- 一个转向生物定义的范式正在进行中.
- 生物学PD定义的关键支柱包括α-synuclein聚合,神经退行和遗传学.
结论:
- 提出了PD的生物学定义,类似于阿尔茨海默氏症和亨廷顿病.
- 在体内检测特定标记物可以使早期的PD诊断成为可能.
- 早期诊断对于开发和应用改变疾病的治疗方法至关重要.
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


